Table 3 Patient characteristics in relation to age interval
From: Cortical microvascular raspberries and ageing: an independent but not exclusive relationship
Age interval | 20–29 | 30–39 | 40–49 | 50–59 | 60–69 | 70–79 | 80–89 | 90–99 | Total |
|---|---|---|---|---|---|---|---|---|---|
n | 9 | 14 | 23 | 37 | 32 | 100 | 37 | 11 | 263 |
Female sex | 4/9 (44%) | 6/14 (43%) | 10/23 (43%) | 12/37 (32%) | 12/32 (38%) | 27/100 (27%) | 11/37 (30%) | 1/11 (9%) | 83/263 (32%) |
Median brain weight | 1270 g | 1430 g | 1400 g | 1410 g | 1343 g | 1303 g | 1269 g | 1273 g | 1320 g |
ADNC | 0/9 (0%) | 0/14 (0%) | 1/23 (4%) | 0/37 (0%) | 3/32 (9%) | 7/100 (7%) | 6/37 (16%) | 4/11 (36%) | 21/263 (8%) |
LBD or MSA | 0/9 (0%) | 0/14 (0%) | 0/23 (0%) | 4/37 (11%) | 3/32 (9%) | 12/100 (12%) | 1/37 (3%) | 0/11 (0%) | 21/263 (8%) |
FTLD | 0/9 (0%) | 0/14 (0%) | 0/23 (0%) | 4/37 (11%) | 4/32 (13%) | 17/100 (17%) | 4/37 (11%) | 0/11 (0%) | 29/263 (11%) |
VCI | 0/9 (0%) | 0/14 (0%) | 0/23 (0%) | 1/37 (3%) | 1/32 (3%) | 10/100 (10%) | 5/37 (14%) | 3/11 (27%) | 21/263 (8%) |
Mixed/other NDD | 0/9 (0%) | 0/14 (0%) | 0/23 (0%) | 0/37 (0%) | 5/32 (16%) | 20/100 (20%) | 13/37 (35%) | 3/11 (27%) | 41/263 (16%) |
NDD and VCI, total | 0/9 (0%) | 0/14 (0%) | 1/23 (4%) | 9/37 (24%) | 16/32 (50%) | 66/100 (66%) | 29/37 (78%) | 10/11 (91%) | 131/263 (50%) |
CVI, one | 0/9 (0%) | 1/14 (7%) | 3/23 (13%) | 3/36 (8%) | 2/31 (6%) | 15/97 (15%) | 6/35 (17%) | 4/11 (36%) | 34/256 (13%) |
CVI, multiple | 2/9 (22%) | 0/14 (0%) | 1/23 (4%) | 5/36 (14%) | 14/31 (45%) | 34/97 (35%) | 14/35 (40%) | 5/11 (45%) | 75/256 (29%) |
CVI, total | 2/9 (22%) | 1/14 (7%) | 4/23 (17%) | 8/36 (22%) | 16/31 (52%) | 49/97 (51%) | 20/35 (57%) | 9/11 (82%) | 109/256 (43%) |
C-ASCL | 0/8 (0%) | 0/12 (0%) | 3/21 (14%) | 6/35 (17%) | 12/32 (38%) | 57/97 (59%) | 20/37 (54%) | 7/11 (64%) | 105/253 (42%) |
C-SVD | 0/9 (0%) | 0/14 (0%) | 6/22 (27%) | 10/37 (27%) | 10/32 (31%) | 47/97 (48%) | 22/36 (61%) | 4/10 (40%) | 99/257 (39%) |
Cardiac hypertrophy | 0/5 (0%) | 0/7 (0%) | 5/14 (36%) | 6/19 (32%) | 14/30 (47%) | 39/94 (41%) | 16/36 (44%) | 6/10 (60%) | 86/215 (40%) |
Nephrosclerosis | 0/7 (0%) | 0/10 (0%) | 2/18 (11%) | 2/31 (6%) | 8/31 (26%) | 51/100 (51%) | 23/37 (62%) | 8/11 (73%) | 94/245 (38%) |
HT, no organ damage | 0/9 (0%) | 0/13 (0%) | 2/21 (10%) | 4/37 (11%) | 11/31 (35%) | 31/89 (35%) | 12/37 (32%) | 3/9 (33%) | 63/246 (26%) |
HT, organ damage | 0/9 (0%) | 0/13 (0%) | 2/21 (10%) | 2/37 (5%) | 6/31 (19%) | 19/89 (21%) | 10/37 (27%) | 2/9 (22%) | 41/246 (17%) |
HT, unclassified | 0/9 (0%) | 0/13 (0%) | 1/21 (5%) | 6/37 (16%) | 0/31 (0%) | 5/89 (6%) | 1/37 (3%) | 0/9 (0%) | 13/246 (5%) |
HT, total | 0/9 (0%) | 0/13 (0%) | 5/21 (24%) | 12/37 (32%) | 17/31 (55%) | 55/89 (62%) | 23/37 (62%) | 5/9 (56%) | 117/246 (48%) |
Diabetes mellitus | 0/9 (0%) | 0/13 (0%) | 5/23 (22%) | 6/37 (16%) | 9/29 (31%) | 21/90 (23%) | 10/36 (28%) | 3/11 (27%) | 54/248 (22%) |
Other findings* | 4/9 (44%) | 3/14 (21%) | 6/23 (26%) | 7/37 (19%) | 1/32 (3%) | 7/100 (7%) | 1/37 (3%) | 0/11 (0%) | 29/263 (11%) |